Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice
- PMID: 10979954
Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice
Abstract
It was hypothesized that during mammalian development, the extensive need for hematopoietic cells requires equal contribution to blood cell production from both quiescent and cycling hematopoietic stem cells (HSCs) while maintaining the stem cell pool. To investigate this hypothesis, the engraftment potential of umbilical cord blood (UCB) CD34(+) cells residing in either G(0) (G(0)CD34(+) cells) or G(1) (G(1)CD34(+) cells) phases of the cell cycle was assessed in nonobese diabetic/severe combined immune-deficient (NOD/SCID) mice. Whereas the level of chimerism in mice transplanted with UCB G(0)CD34(+) cells was 69.9% +/- 24.0%, mice receiving equal numbers of G(1)CD34(+) cells harbored 46.7% +/- 21.3% human cells 8 weeks posttransplantation. Both groups of cells sustained multilineage differentiation and the production of CD34(+) cells in recipient animals. The relationship between the number of transplanted G(0)CD34(+) or G(1)CD34(+) cells and the level of chimerism was analyzed by a general linear models procedure. Although the initial level of chimerism following transplantation of G(0)CD34(+) cells was higher than that sustained by G(1)CD34(+) cells, the increment in the degree of chimerism obtained with each additional 10(3) cells of either phenotype was identical, suggesting that the reconstitution potential of these 2 types of cells was similar. Of interest is that human cells recovered from primary recipients of both G(0)CD34(+) and G(1)CD34(+) cells engrafted in secondary NOD/SCID recipients, albeit at a substantially lower level, confirming the primitive nature of UCB CD34(+) cells residing in G(1).
Similar articles
-
Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells.Blood. 2002 Jul 1;100(1):120-7. doi: 10.1182/blood.v100.1.120. Blood. 2002. PMID: 12070016
-
Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients.Blood. 2002 Mar 1;99(5):1585-93. doi: 10.1182/blood.v99.5.1585. Blood. 2002. PMID: 11861272
-
Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.Blood. 1998 Mar 15;91(6):1966-76. Blood. 1998. PMID: 9490679
-
In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.Exp Hematol. 2000 Dec;28(12):1470-80. doi: 10.1016/s0301-472x(00)00557-9. Exp Hematol. 2000. PMID: 11146169
-
Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.Blood. 1998 Oct 15;92(8):2641-9. Blood. 1998. PMID: 9763545
Cited by
-
Genomic and proteomic analysis of the impact of mitotic quiescence on the engraftment of human CD34+ cells.PLoS One. 2011 Mar 7;6(3):e17498. doi: 10.1371/journal.pone.0017498. PLoS One. 2011. PMID: 21408179 Free PMC article.
-
Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates.J Clin Invest. 2001 Aug;108(3):447-55. doi: 10.1172/JCI12593. J Clin Invest. 2001. PMID: 11489938 Free PMC article.
-
Expansion of human SCID-repopulating cells under hypoxic conditions.J Clin Invest. 2003 Jul;112(1):126-35. doi: 10.1172/JCI17669. J Clin Invest. 2003. PMID: 12840067 Free PMC article.
-
Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials.Methods Mol Biol. 2009;506:33-58. doi: 10.1007/978-1-59745-409-4_4. Methods Mol Biol. 2009. PMID: 19110618 Free PMC article.
-
Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.PLoS One. 2009 Jul 30;4(7):e6461. doi: 10.1371/journal.pone.0006461. PLoS One. 2009. PMID: 19649289 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical